Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate increased, Hepatitis A antibody, Hepatitis B core antibody, Hepatitis B surface antigen, Hepatitis C antibody
Clinical narrative: Jun2022 pain in my neck again, radiating down my right arm, across my chest & right torso; neck pain, seemed muscular; During my 26Nov admission 200cc of fluid was drained around my heart; Pericarditis; This is a spontaneous report received from a Consumer or other non HCP.  A 41-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 14Jan2022 as dose 3 (booster), single (Lot number: 33130BA) at the age of 40 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: IBUPROFEN. The patient also took other concomitant therapy. Past drug history included: Bacitracin, reaction(s): "Allergy". Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Batch/Lot number: ER7835), administration date: 16Apr2021, when the patient was 39-year-old, for COVID-19 immunisation; BNT162b2 (DOSE 2, SINGLE, Batch/Lot number: EW0167), administration date: 07May2021, when the patient was 40-year-old, for COVID-19 immunisation. The following information was reported: MYALGIA (hospitalization) with onset Mar2022, outcome "unknown", described as "neck pain, seemed muscular"; NECK PAIN (hospitalization) with onset Jun2022, outcome "unknown", described as "Jun2022 pain in my neck again, radiating down my right arm, across my chest & right torso"; PERICARDITIS (hospitalization) with onset 21Nov2022, outcome "recovered with sequelae"; PERICARDIAL EFFUSION (hospitalization) with onset 26Nov2022, outcome "recovered with sequelae", described as "During my 26Nov admission 200cc of fluid was drained around my heart". The patient was hospitalized for pericarditis, pericardial effusion (hospitalization duration: 24 day(s)). The events "neck pain, seemed muscular" and "jun2022 pain in my neck again, radiating down my right arm, across my chest & right torso" required physician office visit. The events "pericarditis" and "during my 26nov admission 200cc of fluid was drained around my heart" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: C-reactive protein: (unspecified date) Unknown results; Multiple test: (unspecified date) no diagnosis was determined; Polymerase chain reaction: (17Nov2022) Negative, notes: Nasal Swab; SARS-CoV-2 test: (17Nov2022) Negative, notes: Nasal Swab. Therapeutic measures were taken as a result of pericarditis, pericardial effusion. Clinical course: Mar2022 neck pain, seemed muscular. Better in 3-4 days. Jun2022 pain in neck again, radiating down right arm, across my chest & right torso. Multiple tests were completed, no diagnosis was determined. 17Nov2022 the pain returned more severe. After 4 days patient went to Emergency room, was diagnosed with Pericarditis. Treated with pain relievers & sent home with a prescription of Colchicine. Patient returned to the hospital twice more in the next 13 days, spending 8 days in the hospital. During my 26Nov admission 200cc of fluid was drained around heart. Patient was released. Severe pain returned 38 days later. Back to ER 07Jan, Released the same day. 09Jan pain returned, back to the ER. Admitted for 8 days. Pain was under control, patient was released. Back to ER 15 days later (31Jan), & admitted again. Patient stayed in for 7 days. Patient met Doctor he was starting a drug study. Patient participated, & completed the study 23Aug. Patient still had pains in chest. DR was still monitoring CRP levels due to continued pains. Adverse events resulted in: [Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization]. No covid prior vaccination. 24 days hospitalization. Patient Recovered with lasting effects. Adverse events treatment: Pericardiocentesis, Multiple prescriptions. Patient received within 2 weeks of vaccination: Tri Low, Ibuprofen.